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Daniela Alosi1*, Laura Line Klitten1,2, Mads Bak1, Helle Hjalgrim2,3, Rikke Steensbjerre Møller2,3 and Niels Tommerup1Abstract
In this study we performed molecular characterization of a patient with an extra ring chromosome derived from
chromosome 14, with severe intellectual disability, epilepsy, cerebral paresis, tetraplegia, osteoporosis and severe
thoraco-lumbal scoliosis. Array CGH analysis did not show any genomic imbalance but conventional karyotyping
and FISH analysis revealed the presence of an interstitial 14q12q24.3 deletion and an extra ring chromosome
derived from the deleted material. The deletion and ring chromosome breakpoints were identified at base-pair level
by mate-pair and Sanger sequencing. Both breakpoints disrupted putative long non-coding RNA genes
(TCONS00022561;RP11-148E17.1) of unknown function. However, the proximal breakpoint was 225 kb downstream
of the forkhead box G1 gene (FOXG1), within the known regulatory landscape of FOXG1. The patient represents the first
case of a r(14) arising from an interstitial excision where the phenotype is compatible with dysregulation of FOXG1. In
turn, the phenotypic overlap between the present case, the FOXG1 syndrome and the r(14) syndrome supports that
dysregulation of FOXG1 may contribute to the classical r(14)-syndrome, likely mediated by dynamic mosaicism.
Keywords: Ring chromosome 14, 14q12, Epilepsy, FOXG1, Intellectual disability, Dynamic mosaicismBackground
Ring chromosome 14 (r(14)) syndrome is a rare cytogenetic
condition leading to a complex array of phenotypic alter-
ations mainly characterized by growth retardation, intel-
lectual disability, distinct facial dysmorphism with broad
and flat nasal bridge, prominent forehead, broad philtrum
and thin upper lip, short stature, microcephaly, scoliosis
and ocular abnormalities such as abnormal retinal pig-
mentation, retinitis pigmentosa, strabismus, glaucoma
and abnormal macula. Furthermore the patients suffer
from intellectual disability, with aggressive and hyper-
active behavior in some cases. Another highly charac-
teristic finding is drug resistant epilepsy with onset
during the first year of life [1-7]. Less than 80 cases
have been reported in the literature and the molecular
mechanisms leading to this phenotype remain to be
elucidated.
Forkhead Box G1 gene (FOXG1) encodes a brain-
expressed winged-helix transcriptional repressor, shown
to be critical for forebrain development. The gene is lo-
cated on 14q12 and disruption and/or dysregulation of
FOXG1 has been shown to cause the FOXG1-syndrome* Correspondence: alosi@sund.ku.dk
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unless otherwise stated.[8-14], characterized by severe postnatal microcephaly,
early-onset epilepsy, brain abnormalities, severe intellec-
tual disability, with absent or minimal language develop-
ment, deficient social interactions including poor eye
contact denoting a syndromic form of autism, dyskinesia
with mixed features of athetosis, chorea and dystonia,
epilepsy, poor sleep patterns, irritability, excessive epi-
sodes of crying and frequent gastro-oesophageal reflux
[8,9,12-15]. In contrast to the r(14)-syndrome, only a
mild distinct facial dysmorphism is observed in the
FOXG1-syndrome, and only in patients with deletions
[12-16]. Here we report a patient with a deleted chromo-
some 14 and an extra ring chromosome, where mate
pair sequencing revealed a balanced excision of a ~
50 Mb segment of chromosome 14, with truncation of
the FOXG1 regulatory landscape, and a phenotype over-
lapping with the r(14)-syndrome.Case presentation
Our patient (deceased in 2009) was an 18 year-old fe-
male patient. She was born from healthy unrelated par-
ents after an uncomplicated pregnancy. She presented
with delayed psychomotor development from approxi-
mately 2 months of age. Subsequently, severe intellectual
disability (ID), cerebral paresis, tetraplegia, osteoporosis,
severe thoraco-lumbal scoliosis, loss of vision, no languagehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tient was permanently wheelchair bound. In addition, the
patient was suffering from treatment-resistant epilepsy
with generalized tonic-clonic seizures (GTCS), often in
series, with onset at about 1 year-of-age. Despite medical
treatment the patient experienced weekly seizures
throughout her life. Dysmorphic facial features were not
mentioned in the medical record. Computed tomography,
performed at 1 year of age, showed microcephaly. Brain
magnetic resonance imaging performed at 3 years of age




Conventional cytogenetic analysis performed during child-
hood showed a deletion of 14q24.2 together with a marker
chromosome. The karyotype was reported as: 47,XX,del
(14)(q24.2) +mar. Genome-Wide Human SNP array 6.0Figure 1 Chromosome analysis. a: Karyogram of the patient. b: Chromos
position of the breakpoints. Arrow on the right side indicates the fusion of(Affymetrix, Santa Clara, CA, USA) analyzed with Geno-
typing Console version 3.0 (GTC 3.0, Affymetrix, Santa
Clara, CA, USA) did not show any unbalanced features in
the genome (data not shown). Since no copy number vari-
ations were detected by array screening, the ring chromo-
some most likely consisted of the material missing from
the derivative chromosome 14, with the reported karyo-
type: 47,XX, del(14)(q21q32.1) + r(14)? (Figure 1).
Mate-pair and sanger sequencing
In order to fine map the chromosomal breakpoints, we
performed Next Generation mate-pair sequencing
(MPS) (Illumina Genome Analyzer II (GA-II), Illumina
Inc., San Diego, CA, USA) on peripheral blood DNA.
MPS libraries of patient genomic DNA were prepared
according to the manufacturer’s instructions (Mate Pair
Library v2, Illumina) and sequenced 2x36 bases on a
Genome Analyzer IIx (Illumina). A total of 31,960,052
out of 46,169,874 read-pairs could be aligned to theome 14 and the r(14). Arrows on the left indicate the presumed
chromosome bands 14q12 and 14q24.3.
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[17]. Using SVDetect to search for structural variations
[18], we identified four read-pairs defining the breakpoints
on the r(14) chromosome and the del(14) chromosome,
with a resolution of appr. 1 kb at the 14q12 breakpoint,
and 332 bp at the 14q24.3 breakpoint (Figure 2c). The
breakpoints were subsequently Sanger sequenced to iden-
tify their exact locations. Primers were designed with the
use of the Primer3 software [19]. The PCR primer se-
quences were: D1: ttgatgcaaaaatcctcaataaaa (deleted deriva-
tive chromosome14, forward) and D3: gcttttcatgagctggtgtgt
(deleted derivative chromosome 14, reverse). Ring spe-
cific primers were: A1: taaaacagccaaaaattgattaaa (r(14),




Figure 2 Molecular detection of the breakpoints. a: Schematic orientat
the ring chromosome 14. b: Agarose gel electrophoresis of PCR products o
observed at 62°C in patient (P) DNA but not in control (C) samples. NC: ne
breakpoints, with resolutions corresponding to the shaded areas (proximal:
the breakpoints as detected by Sanger sequencing. d: Position of BLAT seq
breakpoints (upper arrows), the proximal two bp (CC) overlap and the dista
in the highly conserved regulatory domain of FOXG1, proximal to the t(2;14(Figure 2a). An internal sequencing primer of the D1-
D3 fragment (D_internal) was: gaaggacctcttcaaggagaa
(deleted derivative chromosome 14, forward). Using
these primers (Figure 2a), we obtained PCR products
from the patient’s DNA but not from control DNA
(Figure 2b). Sequences were read on an automated ca-
pillary sequencer (ABI 3130XL, Life Technologies) and
analyzed with Chromas Pro version 1.5 (Technelysium
Pty Ltd).
The position of the two breakpoints were 29.464.348
(hg19, proximal breakpoint) and 77.391.823 (hg19, dis-
tal breakpoint), with a 2 bp insertion (CC) at the prox-
imal breakpoint, and a 5 bp (GGGGC) deletion at the
distal breakpoint (Figure 2d).b
ion of primers designed to amplify the breakpoints on the deleted and
btained by primers D1-D3 and A1-A3. Specific amplifications (*) were
gative control. c: Mate-pair reads spanning the proximal and distal
~1,000 bp; distal: ~330 bp). The thin grey lines indicate the position of
uences following Sanger sequencing, showing the location of the two
l 5 bp (GGGGC) deletion. e: Position of the proximal r(14) breakpoint
)-breakpoint [13].
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breakpoint regions. However, both breakpoints disrupted
predicted long non-coding RNA genes (lncRNA). The
proximal breakpoint disrupted the lncRNA ENST00
000551227.1/RP11-148E17.1. The distal breakpoint inter-
rupted the lncRNA TCONS 00022561. Importantly, the
proximal breakpoint mapped ~225 Kb downstream of
FOXG1 (Figure 2e), a member of a transcription factor
family critical for cortical development [8,9,20].
Fluorescence in Situ Hybridization (FISH)
We validated the MPS results by Fluorescence In Situ
Hybridization (FISH) performed according to standard
protocols using 250 ng biotin-14-dATP-labelled bacterial
artificial chromosomes (BACs). We used the following
BAC probes: RP11-24K5 (14q24.1), RP11-950C14
(14q24.3), RP11-35D12 (14q24.1) mapping to the pre-
dicted excised 14q24-region. The FISH analysis con-
firmed that the ring chromosome was composed of the
excised region from 14q (Figure 3a). In order to exclude
the possibility that a centromere on the ring chromo-
some contained centromeric chromosome 14 material,
we performed FISH using α-satellite DNA probes
(Oncor, Gaithersburg, MD). As expected, alpha-satellite
signals were observed on all chromosomes except on the
ring (Figure 3b). Since the ring was detected in all cells
suggesting that it was stable, we presume that α non-
satellite DNA containing neocentromere has been formed.Figure 3 FISH analyses. a: The signals of BAC clone RP11-24K5 from the e
b: Absence of α-satellite DNA signal on the r(14).Discussion
We describe a severely affected female patient with a bal-
anced chromosomal rearrangement consisting of an inter-
stitial excision of chromosome 14q12q24 with subsequent
ring formation. The proximal breakpoint at 14q12 dis-
rupted a predicted lncRNA gene located in a gene desert
approximately 225 kb downstream of FOXG1. Several pa-
tients with the FOXG1-syndrome have been reported with
deletions or balanced rearrangements in the same down-
stream regulatory area of FOXG1 [e.g. 8,13]. Thus, the
present breakpoint is located between FOXG1 and the
t(2;14)(q13;q13) breakpoint described in ref. 13 (Figure 2e),
supporting the involvement of a long-range position effect,
where distally located cis-regulatory elements are moved
in trans with respect to the FOXG1-promoter [21]. The
FOXG1-syndrome (former congenital variant of Rett syn-
drome) is a severe neurodevelopmental disorder classified
by early onset of symptoms, including psychomotor delay,
epilepsy and microcephaly [8-14]. These features were all
present in our patient, along with many of the features of
the r(14)-syndrome (Table 1). In contrast to the distinct
facial features of the r(14)-syndrome, there was no report
of dysmorphic features in our patient. This correlates with
other reports of non-dysmorphic patients with the
FOXG1-syndrome. Both the proximal and distal break-
points disrupted predicted lncRNA genes. However, there
is no known phenotype associated with either of these
ncRNA genes, and the patient does not have any majorxcised region are on the normal chromosome 14 and on the r(14).
Table 1 Clinical features present in our patient, in the FOXG1-syndrome and in the r(14)-syndrome
This study FOXG1-syndrome* r(14)-syndrome**
Karyotype/molecular
characteristics
47, XX, del(14)(q12q24.3), + (r14) FOXG1 point mutations, 14q12 CNV Ring chromosome 14
Number of cases reported so far Unique ~ 50 Less than 80 cases
Clinical features
Pregnancy and neonatal period Normal Normal Normal
Postnatal growth deficiency Moderate Mild to moderate
Intellectual disability Severe Severe Mild to severe
Developmental delay Delayed psychomotor development
since 2 months of age
Severe Severe
Postnatal microcephaly Yes Postnatal microcephaly (-4/-6 SD) Reported in the majority
Speech-language development No speech Absent or minimal speech Severely affected
Social interaction No eye-contact Poor eye contact, denoting a syndromic
form of autism
Autistic traits
Walking Unable Unable N/A
Loss of psychomotor skills Hand skills, speech, communication skills N/A
Skeletal abnormalities Osteoporosis and thoraco-lumbal
scoliosis
Scoliosis, kyphosis Scoliosis
Facial dysmorphism N/A Only in patients with deletions Mild. Peculiar facial appearance only in patients with deletion
size greater than 0.65 Mb, including blepharophimo-sis,
short bulbous nose, long philtrum, epicantal folds, small mouth
Behaviour N/A Poor sleep pattern, irritability (especially in infancy),
excessive crying/weeping, inappropriate laughing
Hyperactivity, aggressiveness
Epilepsy Therapy-resistant epilepsy. Seizure type:
GTCS, often in series. Onset: 1 year-of-age.
Infantile spasms in association with duplications,
CPS, GTCS, myoclonic seizures
Early-onset (in most cases within the first year of life),
typically drug-resistant GTCS, CPS
Ocular abnormalities Loss of vision Strabismus Retinal pigmentary anomalies, retinitis pigmentosa,
cataract, strabismus, maculopathy, glaucoma, myopia
Motor and dyskinesias Tetraplegia Hypotonia, spasticity, abnormal locomotion, stereotypic
movements (especially hand movements), dyskinesias
(chorea/athetosis/dystonia), bruxism, drooling
(sialorrhea), tongue protruding movements
Hypotonia, motoric stereotypies, hand flapping, echolalia
Gastrointestinal and
respiratory systems
N/A Feeding difficulties, aspiration, gastro-esophageal
reflux, constipation, breathing abnormalities
Susceptibility to infections of the respiratory tract
Brain Imaging MRI (1994): central and cortical atrophy,
corpus callosum agenesis. Suspicion of
changes in cortical-spinal tracts
Simplified gyral pattern, white matter hypoplasia
(frontal), hypogenesis of corpus callosum,
variable mild frontal pachygyria
White matter hypoplasia, corpus callosum
abnormalities, hippocampal dysmorphisms,
cerebellar structural abnormalities











Alosi et al. Molecular Cytogenetics  (2015) 8:24 Page 6 of 7clinical feature that has not been reported previously in
the FOXG1- or r(14)-syndromes. It has been suggested
that genes within the 14q11q13 region determine the vis-
ual impairment and epilepsy associated with the r(14)-syn-
drome, with FOXG1 being one of the candidate genes [7].
Indeed, the considerable phenotypic overlap between the
present case, the FOXG1-syndrome and the r(14)-syn-
drome (Table 1) suggests that dysregulation of FOXG1
may be a significant factor behind the classical r(14)-
syndrome.
Conclusions
We present a balanced rearrangement with an excision
of 14q12q24, and an extra ring chromosome composed
of the excised material. The severe clinical features are
compatible with the FOXG1-syndrome, in line with the
localization of the 14q12-breakpoint 225 kb downstream
of FOXG1, within the regulatory domain where break-
points are known to dysregulateFOXG1 by long range
position effects. Moreover, the clinical overlap between
our case, the FOXG1-syndrome and the classical r(14)-
syndrome, supports that dysregulation of FOXG1 may
be an important factor involved in the clinical features
of the classical r(14)-syndrome. Since classical r(14)
chromosomes would rarely have breakpoints within the
FOXG1-regulatory domain, a likely mechanism for such
a dysregulation may be the dynamic mosaicism associ-
ated with ring chromosomes, where sister chromatid ex-
changes within the ring lead to interlocked rings with
subsequent breakage/reunion and/or aneuploidy mosai-
cism. Such a mechanism could also be relevant for the
clinical features associated with other ring chromo-
somes, e.g. the development of tumors associated with the
loss of specific tumor suppressors [22], and the epilepsy
associated with loss of e.g. CHRNA4 and/or KCNQ2 in
ring chromosome 20 mosaicism [23].
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